Sintx Technologies (SINT) EBIT Margin Growth (1y) (2014 - 2026)
Sintx Technologies (SINT) EBIT Margin Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 851.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 241.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -313.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sintx Technologies | 17,274.80 | -1.87 Mn | 144,000.00 | -19,815.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19,815.00 |
| Dec 31, 2025 | -47,975.00 |
| Sep 30, 2025 | -81,098.00 |
| Jun 30, 2025 | -144,942.00 |
| Mar 31, 2025 | -18,044.00 |
| Dec 31, 2024 | -1,767.00 |
| Sep 30, 2024 | -26,896.00 |
| Jun 30, 2024 | 36,641.00 |
| Mar 31, 2024 | 19,457.00 |
| Dec 31, 2023 | 7,472.00 |
| Sep 30, 2023 | 12,260.00 |
| Jun 30, 2023 | 47,769.00 |
| Mar 31, 2023 | 157,263.00 |
| Dec 31, 2022 | 119,370.00 |
| Sep 30, 2022 | 52,637.00 |
| Jun 30, 2022 | 118,002.00 |
| Mar 31, 2022 | 58,031.00 |
| Dec 31, 2021 | 35,901.00 |
| Sep 30, 2021 | 249,678.00 |
| Jun 30, 2021 | -136,705.00 |